SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : tech. enhancements -- half-life/stealthing -- Ignore unavailable to you. Want to Upgrade?


To: keokalani'nui who wrote (49)12/9/2004 6:59:21 PM
From: scaram(o)uche  Respond to of 53
 
DAC(TM):GRF is a chemically modified form of GRF that, followingsubcutaneous injection, covalently and permanently bonds to albumin, thedominant protein in blood, thus dramatically prolonging the half-life of GRFfrom minutes to days (more than 10 days in humans). More importantly, DAC cannot be detected in sprinters or baseball players after albumin binding occurs.